Group Inc. (NYSE:CIT) cit.com ,
a leading provider of commercial lending and leasing services, today
announced that it served as Joint Lead Arranger and Administrative Agent
in a $325 million senior secured credit facility to LCI Helicopters
(LCIH), the helicopter leasing subsidiary of Lease Corporation
Physicians Realty Trust (NYSE:DOC) (the “Company”), a self-managed
healthcare real estate company, announced today that it has closed on
previously announced acquisitions consisting of seven different
properties totaling approximately $114.1 million of
- Investment in new plant producing six brands including Oreo and Ritz is part of company's supply-chain reinvention plan - During its lifetime, state-of-the-art plant will generate hundreds of jobs and sustain many more in local economy
- At official ceremony, Bahrain industry minister Dr.
Patterson Companies, Inc. (Nasdaq: PDCO ),
at its annual investor day, this morning announced a new strategic
partnership with Abaxis, Inc. (NasdaqGS: ABAX), a medical products
company that manufactures point-of-care blood instrumentation and
consumables to the medical, research and veterinary markets.
(TSX Symbol: ACC) – Amica Mature Lifestyles Inc. (“Amica”
or the “Company”) is pleased to announce the voting results from its
annual meeting of shareholders (the “Shareholders”) held on September
30, 2014 (the “Meeting”) in Toronto, Ontario.
HSBC Bank USA, N.A. today announced it is adding $3 billion more to its
international loan program, raising the program’s total funding to $5
billion, as demand by U.S. small and medium size businesses looking to
export or expand internationally continues to rise.
Glatfelter (NYSE: GLT) announced that today it completed the previously
announced acquisition of Spezialpapierfabrik Oberschmitten GmbH (SPO)
from FINSPO Beteiligungs-GmbH for €8.5 million (approximately U.S.$11
SPO’s plant is located near Frankfurt, Germany.
8x8, Inc. (NASDAQ:EGHT), a provider of cloud-based unified
communications, contact center and collaboration solutions, today
announced it will report its second quarter fiscal 2015 results for the
period ended September 30, 2014 after market close on Wednesday, October
By Ben Eisen and Sue Chang, MarketWatch
NEW YORK (MarketWatch) -- Shares in drug companies that are developing a potential treatment for Ebola are active Wednesday after a case of the deadly disease was reported in the U.S.
Tekmira Pharmaceuticals Corp.(TKMR) : The Canadian biotech is seen as a play on treatment of Ebola, after the first case was reported in the U.S. In August, the U.S. Food and Drug Administration gave verbal approval to change the status on its drug, known as TKM-Ebola, to a partial clinical hold from a full clinical hold.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.